그린생명과학
114450KOSDAQ· 의료용 물질 및 의약품 제조업2,175원-40 (-1.81%)마감
52주 위치
1,6734,59017%신고가 대비 -52.61%
- 시가총액
- 435억
- PER
- 5.83
- PBR
- 0.97
- EPS(TTM)
- 373원
- BPS
- 2,243원
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021(별도) | 2022(별도) | 2023(별도) | 2024(별도) | 2025(별도) |
|---|---|---|---|---|---|
| ROE | -5.57% | -6.47% | -36.93% | 4.36% | 0.30% |
| ROA | -4.36% | -5.25% | -30.79% | 3.52% | 0.22% |
| 영업이익률 | -18.35% | -10.84% | -20.76% | 1.52% | 0.51% |
| 순이익률 | -12.38% | -9.66% | -73.13% | 6.28% | 0.27% |
| 매출총이익률 | -8.96% | -3.72% | -10.33% | 11.99% | 6.12% |
| 부채비율 | 27.85% | 18.60% | 21.90% | 25.80% | 43.29% |
| 유동비율 | 176.44% | 280.22% | 293.67% | 264.50% | 204.10% |
| 매출 성장률(YoY) | — | 44.07% | -38.72% | 11.14% | 62.26% |
| 영업이익 성장률(YoY) | — | — | — | — | -45.80% |
| 순이익 성장률(YoY) | — | — | — | — | -92.95% |
| FCF | -28.32억 | -60.3억 | -9,480만 | 1.23억 | -4.96억 |
| FCF 마진 | -11.18% | -16.52% | -0.42% | 0.50% | -1.23% |
| CAPEX/매출 | 13.59% | 4.05% | 2.08% | 1.62% | 2.13% |
| 항목 | 2021 3Q(별도) | 2021 4Q(별도) | 2022 1Q(별도) | 2022 2Q(별도) | 2022 3Q(별도) | 2022 4Q(별도) | 2023 1Q(별도) | 2023 2Q(별도) | 2023 3Q(별도) | 2023 4Q(별도) | 2024 1Q(별도) | 2024 2Q(별도) | 2024 3Q(별도) | 2024 4Q(별도) | 2025 1Q(별도) | 2025 2Q(별도) | 2025 3Q(별도) | 2025 4Q(별도) | 2026 1Q(별도) | 2026 2Q(별도) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -1.35% | -2.72% | 0.18% | -0.87% | -0.63% | -5.12% | -1.63% | -1.93% | -0.90% | -31.54% | 2.41% | 3.08% | -2.56% | 0.71% | -3.24% | 0.10% | 1.39% | 1.97% | 4.70% | 11.02% |
| ROA | -1.12% | -2.13% | 0.14% | -0.71% | -0.52% | -4.15% | -1.33% | -1.56% | -0.76% | -26.30% | 2.05% | 2.50% | -2.15% | 0.57% | -2.61% | 0.08% | 1.05% | 1.46% | 3.48% | 8.31% |
| 영업이익률 | -16.38% | -22.20% | 0.33% | -9.91% | -15.47% | -42.74% | -27.06% | -16.05% | -7.66% | -49.93% | 11.04% | 10.33% | -14.09% | -6.22% | -23.30% | 0.50% | 0.92% | 9.67% | 3.76% | 9.48% |
| 순이익률 | -12.19% | -19.36% | 0.72% | -4.45% | -5.32% | -62.84% | -22.54% | -14.10% | -6.33% | -379.55% | 16.18% | 19.48% | -24.66% | 3.65% | -23.52% | 0.31% | 4.32% | 5.77% | 11.29% | 23.01% |
| 매출총이익률 | -6.34% | -12.12% | 5.45% | -4.02% | -6.22% | -29.19% | -17.83% | -5.73% | -1.13% | -30.13% | 20.61% | 19.25% | -2.19% | 5.73% | -10.93% | 4.89% | 6.45% | 13.86% | 7.37% | 12.71% |
| 부채비율 | 21.15% | 27.85% | 29.30% | 22.65% | 17.47% | 18.60% | 16.39% | 25.18% | 18.18% | 21.90% | 19.55% | 20.09% | 21.05% | 25.80% | 29.50% | 33.04% | 43.31% | 43.29% | 39.89% | 32.34% |
| 유동비율 | 220.82% | 176.44% | 175.69% | 203.48% | 262.00% | 280.22% | 305.18% | 232.42% | 288.20% | 293.67% | 321.33% | 316.25% | 295.80% | 264.50% | 235.74% | 219.64% | 189.98% | 204.10% | 217.06% | 290.68% |
| 매출 성장률(YoY) | — | — | — | — | 3.42% | -43.89% | -73.02% | -32.93% | 12.26% | -17.11% | 66.95% | -5.32% | -40.40% | 88.93% | -25.52% | 66.02% | 155.06% | 81.72% | 219.16% | 65.84% |
| 영업이익 성장률(YoY) | — | — | — | — | — | — | -2279.76% | — | — | — | — | — | — | — | -257.21% | -91.91% | — | — | — | 3020.65% |
| 순이익 성장률(YoY) | — | — | — | — | — | — | -947.60% | — | — | — | — | — | — | — | -208.26% | -97.32% | — | 187.40% | — | 12014.83% |
| FCF | -9.68억 | 12.57억 | -50.89억 | 24.36억 | -30.09억 | -4.51억 | -2.13억 | -8.13억 | -3.37억 | 12.68억 | -11.07억 | 8.38억 | 14.2억 | -13.05억 | -3.67억 | -32.06억 | 32.49억 | -1.72억 | -27.04억 | 27.64억 |
| FCF 마진 | -15.05% | 15.88% | -35.04% | 22.37% | -45.23% | -10.16% | -5.44% | -11.13% | -4.51% | 34.45% | -16.92% | 12.12% | 31.90% | -18.76% | -7.54% | -27.93% | 28.63% | -1.36% | -17.39% | 14.52% |
| CAPEX/매출 | 10.46% | 21.40% | 4.04% | 4.27% | 7.02% | 0.94% | 1.21% | 1.82% | 1.36% | 4.97% | 0.12% | 2.40% | 8.25% | 1.99% | 2.24% | 1.45% | 0.71% | 3.98% | 0.92% | 2.83% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 00:02· 별도 · 산식은 항목 툴팁